Silexion Therapeutics Corp

Silexion Therapeutics Corp financial statements

Silexion Therapeutics Corp's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 11.91M10-K
Cash and equivalentsUSD 5.99M10-Q
Total debtUSD 468KEODHD

Silexion Therapeutics Corp financials on 6ix · Silexion Therapeutics Corp on 6ix